Definitive Contract HHSN272201500032C

This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Macrogenics, Inc., a for-profit manufacturer, for research and development services related to advanced development. The contract has a ceiling value of $56,058,625.93 and was awarded on September 29, 2006, with an ultimate completion date of September 28, 2011. The contract is not set-aside for any...

This is a Cost Plus Fixed Fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract, which has a ceiling value of $516,234.16, is for the identification of anti-HIV therapeutics and topical microbicides. It falls under NIAID's In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract...

This federal contract award is for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The prime contractor is Southern Research Institute, a non-profit organization that provides advanced technologies and contract research services, including drug discovery and development, emerging infectious disease research, medicinal chemistry, and toxicology. The contract, with a potential value of $494,934.25, is...

This is a $12,436,225.00 Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to BBI Biotech Research Laboratories Incorporated on June 30, 1998 for AIDS research (basic). The contract has an ultimate completion date of December 31, 2007 and was not set aside for any special designation. As NIAID is the research arm of the National Institutes of Health focused on infectious diseases, this contract is likely...

This is a $26,065,720.00 cost-plus-fixed-fee delivery order awarded to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is for the manufacture of human flu challenge material, which supports IAVI's mission to develop safe and effective preventive vaccines for infectious diseases. The award is part of IAVI's existing indefinite...

This is a definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $156,240,393.28, is for "Other Function - Microbial Genome Centers" and does not have a set-aside designation. The contract was awarded on September 15, 2003, with a completion date of December 31, 2009. The contract type is Cost No Fee, indicating the contractor is...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The $999,976 cost-plus-fixed-fee contract is for services to identify inhibitors of HIV-1 capsid dimerization as part of NIAID's In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract has no set-aside designation and is...

This is a $20,654,816.99, cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to United Biomedical, Inc. for HIV vaccine design and development teams for prevention and treatment. The contract has a completion date of June 29, 2010 and was awarded on June 30, 2005. This contract is not associated with a set-aside and does not indicate the use of any small business program. United Biomedical, Inc. is a for-profit, self-certified...

This federal contract award is a Cost Plus Fixed Fee Delivery Order under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The award has a ceiling value of $3,828,720.00 and an ultimate completion date of April 4, 2026. The contract is for the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, to provide a range of research,...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...